The ICH E6(R3) “Good Clinical Practice” Guideline provides a unified standard to facilitate the mutual acceptance of clinical [...]

Alpha-9 funds targeted radiopharmaceuticals; Evommune pursues chronic urticaria and atopic dermatitis; Agomab Therapeutics advances lead candidate [...]

Adding Merck & Co.’s new cardiovascular drug Winrevair to background therapy helped people with severe lung [...]